Longboard Pharmaceuticals Inc [LBPH] stock is trading at $27.03, up 20.19%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LBPH shares have gain 29.89% over the last week, with a monthly amount glided 48.43%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Longboard Pharmaceuticals Inc [NASDAQ: LBPH] stock has seen the most recent analyst activity on May 01, 2024, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $36. Previously, Citigroup started tracking the stock with Buy rating on February 16, 2024, and set its price target to $40. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $13 on April 27, 2023. Evercore ISI initiated its recommendation with a Outperform and recommended $35 as its price target on April 07, 2021. Guggenheim started tracking with a Buy rating for this stock on April 06, 2021, and assigned it a price target of $27. In a note dated April 06, 2021, Citigroup initiated an Buy rating and provided a target price of $37 on this stock.
Longboard Pharmaceuticals Inc [LBPH] stock has fluctuated between $3.60 and $28.15 over the past year. Currently, Wall Street analysts expect the stock to reach $29.33 within the next 12 months. Longboard Pharmaceuticals Inc [NASDAQ: LBPH] shares were valued at $27.03 at the most recent close of the market. An investor can expect a potential return of 8.51% based on the average LBPH price forecast.
Analyzing the LBPH fundamentals
Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at -7863.38%, Pretax Profit Margin comes in at -7244.0%, and Net Profit Margin reading is -7244.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.5 and Total Capital is -0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.47 points at the first support level, and at 19.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 29.36, and for the 2nd resistance point, it is at 31.69.
Ratios To Look Out For
For context, Longboard Pharmaceuticals Inc’s Current Ratio is 31.43. Further, the Quick Ratio stands at 31.43, while the Cash Ratio is 5.29.
Transactions by insiders
Recent insider trading involved ARENA PHARMACEUTICALS INC, Former 10% Owner, that happened on Jan 25 ’24 when 3.98 million shares were sold.
